Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2000

View Archived Issues

Safety of clopidogrel shown to be superior to ticlopidine after coronary stenting

Smoking linked to increased TF expression in atherosclerotic plaques

Anadys signs antifungal collaboration with Pharmacia

McGill University licenses fungal genomics technology to Mycota Biosciences

Avanir forms subsidiary to exploit human MAb technology

CuraGen and Abgenix select 24 antibody drug targets for cancer indications

Bioniche reports preclinical findings for MCC in prostate cancer

Copernicus Therapeutics awarded SBIR grant to develop episomal vectors for breast cancer therapy

Therapies aimed at reducing free radicals may innovate treatment of septic shock

Research associates synapsins with cyclosporine-induced hypertension

Researchers establish the effect of beta-blocker nebivolol on nitric oxide production

Antiretroviral therapy reduces but does not eliminate seminal HIV shedding

Medicis obtains rights to Corixa's psoriasis product PVAC

MCA lifts clinical hold on Vasomax

Positive phase II results reported for IoGen in FBD

United submits first sections of Uniprost NDA to FDA for pulmonary hypertension

Genetic sequence of cholera bacterium published

Antineoplastic agents under development at Merck & Co.

New compounds interacting with glutathione reductase useful for cataracts, etc.

New compounds under development at BioChem Pharma for treatment of antiviral infections

Fujisawa receives patent for imidazole agents

Novel thrombin inhibitors under study at LG Chemical

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Novel series of group II mGlu receptor agonists described at ACS meeting

deCODE Genetics and Roche reach milestone in Alzheimer's research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026